|
Volumn 16, Issue SUPPL. A, 2000, Pages
|
Medical therapy versus revascularization: The atorvastatin versus revascularization treatment AVERT trial
|
Author keywords
Clinical trials; Risk factors
|
Indexed keywords
ATORVASTATIN;
HEPTANOIC ACID DERIVATIVE;
HYPOCHOLESTEROLEMIC AGENT;
PYRROLE DERIVATIVE;
ARTICLE;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
CORONARY ARTERY DISEASE;
DECISION MAKING;
FEMALE;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
MALE;
METHODOLOGY;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
RANDOMIZED CONTROLLED TRIAL;
SAFETY;
SURVIVAL RATE;
TRANSLUMINAL CORONARY ANGIOPLASTY;
TREATMENT OUTCOME;
ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY;
ANTICHOLESTEREMIC AGENTS;
CORONARY ARTERY BYPASS;
CORONARY DISEASE;
DECISION MAKING;
FEMALE;
HEPTANOIC ACIDS;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL REVASCULARIZATION;
PYRROLES;
SAFETY;
SURVIVAL RATE;
TREATMENT OUTCOME;
|
EID: 0033632182
PISSN: 0828282X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (4)
|